Polycystic Ovary Syndrome: Anogenital Distance as a Marker of Prenatal Androgenic Environment and Review and Comparison of Diagnostic Criteria

    January 2020 in “ Proyecto de investigación: ”
    Hernández Peñalver, Ana Isabel
    TLDR Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.
    The document presents findings from a study that explored the relationship between anogenital distance (AGD) and polycystic ovary syndrome (PCOS) in adult Mediterranean women. The study, which involved 300 patients, found that women with PCOS had significantly longer AGD, particularly the distance from the anterior clitoral surface to the upper verge of the anus (AGDAC), compared to controls. Women in the upper tertile for AGDAC were 2.9 times more likely to have PCOS. The study also demonstrated that combining AGDAC measurements with anti-Müllerian hormone (AMH) levels provided greater diagnostic accuracy for PCOS than either measurement alone, with an area under the curve of 0.87 for diagnosing PCOS. These results suggest that AGDAC could be an effective clinical tool for diagnosing PCOS and that the intrauterine hormonal environment may play a significant role in the development of PCOS. The combination of AGDAC and AMH could improve the diagnosis and management of PCOS patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results